-
1.发明授权Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith 有权用于治疗急性呼吸窘迫综合征（ARDS）的组合物和用途以及与其相关的临床疾病公开(公告)号：US08822409B2
公开(公告)日：2014-09-02
申请号：US12665263
申请日：2008-06-20
CPC分类号： A61K38/08 , A61K38/10 , A61K38/16 , G01N33/5088 , G01N2800/125
摘要： Polypeptides are identified through an assay based on inhibiting AP-I signalling activity and others to treat acute respiratory distress syndrome (ARDS) and clinical disorders associated with the development of ARDS.
摘要翻译： 通过基于抑制AP-1信号传导活性和其他治疗急性呼吸窘迫综合征（ARDS）和与ARDS发展相关的临床疾病的测定来鉴定多肽。
-
2.发明申请COMPOSITIONS AND USES THEREOF FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) AND CLINICAL DISORDERS ASSOCIATED WITH THEREWITH 有权治疗与急性呼吸道综合征（ARDS）和临床症状相关的急性呼吸综合征（ARDS）及临床症状的组合物及其用途公开(公告)号：US20110053831A1
公开(公告)日：2011-03-03
申请号：US12665263
申请日：2008-06-20
CPC分类号： A61K38/08 , A61K38/10 , A61K38/16 , G01N33/5088 , G01N2800/125
摘要： Polypeptides are identified through an assay based on inhibiting AP-I signalling activity and others to treat acute respiratory distress syndrome (ARDS) and clinical disorders associated with the development of ARDS.
摘要翻译： 通过基于抑制AP-1信号传导活性和其他治疗急性呼吸窘迫综合征（ARDS）和与ARDS发展相关的临床疾病的测定来鉴定多肽。
-
搜索结果
2 条记录 (耗时 0.015 秒)
筛选
AND
AND
过滤
NOT
NOT
扫码加群
